Skip to main content
Concerns raised over pharma monopolies as ‘next generation’ covid jab approved
File photo dated 31/07/21 of a person receiving a Covid-19 jab

CAMPAIGNERS raised concerns over pharmaceutical monopolies today as a “next generation” coronavirus booster jab needed only once a year was approved for use in adults in Britain.

The UK Medicines & Healthcare products Regulatory Agency authorised the new Covid-19 injection from US pharmaceutical giant Moderna.

It is an updated version of the Moderna jab that has already been in use with some people who got their first, second or booster injections.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
Similar stories
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, Cal
Science and Society / 18 December 2024
18 December 2024
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
An electron micrograph of HIV-1 virus particles (colourized
Features / 13 September 2024
13 September 2024
ALAN ROSSI SILVA argues that Gilead’s HIV prevention drug, while promising, highlights systemic failures in the pharmaceutical industry, showing the need to shift towards state-owned drug development and production
NO ONE IS SAFE: Palestinian children forced to evacuate a sc
Features / 24 August 2024
24 August 2024
The Palestinian Ministry of Health has confirmed the reemergence of polio in the Gaza Strip as Israel continues to decimate healthcare infrastructure, says ANA VRACAR